Literature DB >> 2385558

Pyoderma gangrenosum associated with erythroid hypoplasia.

C K Wong1, K K Pun, C C Lum, S W Lee, M M Ng, C C Wang.   

Abstract

Pyoderma gangrenosum is most commonly associated with inflammatory bowel disease and rheumatoid arthritis, but it has been associated with various haematological malignancies. We describe its association with primary erythroid hypoplasia without thymoma in an 80 year old woman who presented with septicaemia complicating urinary tract infection. Spontaneous healing of an extensive lesion was observed.

Entities:  

Mesh：

Year:  1990        PMID： 2385558      PMCID： PMC2429404          DOI： 10.1136/pgmj.66.774.312

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  Pyoderma gangrenosum: a reappraisal of associated systemic diseases.

Authors:  J G Hickman; G S Lazarus
Journal:  Br J Dermatol       Date:  1980-02       Impact factor: 9.302

2.  Pyoderma gangrenosum, rheumatoid arthritis, and diabetes mellitus.

Authors:  J A Philpott; R W Goltz; R K Park
Journal:  Arch Dermatol       Date:  1966-12

Review 3.  Pyoderma gangrenosum: a review.

Authors:  S M Schwaegerle; W F Bergfeld; D Senitzer; R T Tidrick
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

Review 4.  Pyoderma gangrenosum as a manifestation of leukemia in childhood.

Authors:  A L Gilman; B A Cohen; A H Urbach; J Blatt
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

5.  Atypical pyoderma gangrenosum with leukemia.

Authors:  S J Lewis; M B Poh-Fitzpatrick; R R Walther
Journal:  JAMA       Date:  1978-03-06       Impact factor: 56.272

6.  Pyoderma gangrenosum: a review of 86 patients.

Authors:  F C Powell; A L Schroeter; W P Su; H O Perry
Journal:  Q J Med       Date:  1985-05

7.  Pyoderma gangrenosum in myelodysplasia and acute leukaemia.

Authors:  P Jacobs; S Palmer; E C Gordon-Smith
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

8.  Pyoderma gangrenosum with myelofibrosis.

Authors:  K T Kanel; F J Kroboth; W M Swartz
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.